MedTrace Logo

Pancreatic Duct Stent for Acute Necrotizing Pancreatitis

NCT03115918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-02-17

No results posted yet for this study

Summary

The research design is a randomized prospective clinical study comparing the incidence of Walled Off Necrosis (WON) in patients with acute necrotizing pancreatitis.

Conditions

  • Necrotizing Pancreatitis
  • Walled Off Necrosis

Interventions

DEVICE

Pancreatic Duct Stent Placement

Patients will be randomly allocated to either treatment arm to have a PD stent placed.

OTHER

No Pancreatic Duct Stent Placement

Patients will be randomly allocated to either treatment arm and not receive PD placement.

Sponsors & Collaborators

  • AdventHealth

    lead OTHER

Principal Investigators

  • Shyam Varadarajulu, MD · AdventHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-04
Primary Completion
2020-07-31
Completion
2020-11-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03115918 on ClinicalTrials.gov